Eye Journal

26/05/2026

Our second journal, EYE OPEN, is now accepting submissions for the collection 'AI-Powered Multimodal Ophthalmic Imaging: From Screening to Precision Diagnosis'

We invite original research, reviews, and translational studies on AI-driven methods that enhance the diagnostic power, scalability, and accessibility of ophthalmic imaging. Studies that bridge algorithmic innovation with clinical application or explore cross-modality data fusion are particularly encouraged.

Learn more and submit your work here:

This collection invites original research, reviews, and translational studies on AI-driven methods that enhance the diagnostic power, scalability, and ...

14/05/2026

Come and Meet the Editors in Chief of EYE and EYE OPEN at the RCOphth Congress.

WHERE: Exhibition Theatre, Main Exhibition Hall
WHEN: Monday 18 May, 13.15-14.00

This drop-in session gives delegates the chance to meet the Editors in Chief of Eye, Harminder S Dua, and Eye Open, Winfried Amoaku, to learn more about the journals and ask questions about publishing, peer review, and editorial opportunities.

06/05/2026

Eye is inviting submissions for a Special Collection on Real-Word Data in

We invite original research, methodological perspectives, and invited editorial content on real-world data in ophthalmology, with interest in studies using TriNetX and other large clinical databases

Key dates:
• Expressions of interest by 30 May 2026
• Submission deadline 30 August 2026

Guest Editors: Tiarnan Keenan and Itay Nitzan

https://www.nature.com/eye/

30/04/2026

Soft tissue filler use continues to grow, and so do the risks. This new article in Eye outlines UK consensus guidelines for managing one of the most serious complications, tissue filler induced vision loss.

Although rare, cases have risen sharply, with more than 500 reported worldwide by 2023. Most patients present within minutes, often with severe and irreversible vision impairment, making rapid recognition and response essential.

These guidelines bring together expertise from ophthalmology, aesthetics, and emergency care to provide clear, practical steps for early management and referral.

Read the full article to understand how to respond effectively when every minute counts.

Read more here: https://www.nature.com/articles/s41433-026-04470-9more

14/04/2026

Eye is inviting submissions for a Special Section on Thyroid Eye Disease and Orbital Inflammation.

You can contribute:
• Clinical and translational research
• Advances in medical and surgical therapies
• Imaging and diagnostic approaches
• Outcomes, quality of life, and patient experience
• Future directions and unmet research needs

Key dates:
• Expression of interest by 30 June 2026
• Submission deadline 30 December 2026

Guest Editors: Vickie Lee and Nima Ghadiri

Submit your work and help shape progress in this evolving field.

https://www.nature.com/eye/

09/04/2026

Idiopathic intracranial hypertension is increasing, but care across the UK remains inconsistent.

A review of 8 audits covering 469 patients shows gaps in key areas. Diagnostic standards such as lumbar puncture and venography are not consistently met. Visual field testing is often incomplete at presentation. Basic measures like recording weight are frequently missed, despite obesity being the main risk factor. Referral to weight management services remains limited.

Services with structured pathways and dedicated clinics perform better, showing that standardisation works.

There is a clear need for national quality standards. The proposed RISE-IIH framework aims to reduce variation, improve coordination, and deliver more consistent, patient-centred care.



https://www.nature.com/articles/s41433-026-04358-8

07/04/2026

New research highlights a critical reality in neovascular age-related macular degeneration (nAMD) care: outcomes are not equal.

In this Editorial, we explore findings from the National Ophthalmology Database (NOD) AMD Audit, showing that patients from more deprived communities present with worse vision and experience poorer outcomes, despite receiving similar care once in the NHS pathway.

The message is clear. Inequality begins before treatment starts.

Delays in detection, access to primary eye care, and challenges with long-term engagement all play a role. As therapies evolve, improving early diagnosis and ensuring equitable access must be a priority.

Read the full editorial to understand what needs to change and how we can work together to address these disparities.

https://www.nature.com/articles/s41433-026-04423-2

27/03/2026

The first UK consensus paper on managing Dry Eye Disease relevant to the NHS, detailing the patient pathway from primary to tertiary care involving optometrists, nurse practitioners, general and specialist ophthalmologists, is published in Eye.

“Assessment and management of dry eye disease in the UK: standardising reality-based best practice”

Read here: https://www.nature.com/articles/s41433-026-04375-7

23/03/2026

[EYE OPEN]
New research on persistent epithelial defects (PED) shows that amniotic membrane transplant remains an effective treatment option. In a study of 29 patients, healing was achieved in 75.9% of cases.

The study compared cryopreserved membranes (CAM) with vacuum dried membranes (Omnigen) and found no meaningful difference in outcomes. Both approaches led to a significant reduction in stromal bed thickness, with similar results across corneal and epithelial measurements.

These findings suggest that CAM and Omnigen are equally effective in managing PED. ASOCT also proved valuable for tracking healing with objective, quantitative data.

https://www.nature.com/articles/s44440-025-00007-3

04/03/2026

[EYE OPEN] New review highlights key updates to the English Diabetic Eye Screening Programme:

• 2-year screening for some low-risk patients
• R2 retinopathy split into low/high risk
• OCT used to refine maculopathy referrals

As diabetes prevalence continues to rise, innovations like these will be key to sustaining effective national screening programmes and protecting patient sight.

Read here: https://www.nature.com/articles/s44440-026-00014-y